Biochain Early Screening of Gastric Cancer MG Animation

Biochain (Beijing) Technology Co., Ltd. Was established in 2006. It is a Beijing high-tech enterprise focusing on the industrialization of early diagnosis products for major diseases such as cancer. The company has a 40,000 square meter industrialization base in Beijing Economic and Technological Development Zone, owns nearly 100 domestic and foreign invention patents, and has been approved for dozens of NMPA document products. Its core product, the early diagnosis product of intestinal cancer, was approved for launch in 2015, and is the first approved product for early cancer diagnosis in China. In 2020, the company reached a strategic cooperation with BOE to jointly promote the development of early cancer diagnosis and early intervention.